Plus Therapeutics Reports Q2 2019 Financial and Business Results


You May Also Like

Sun Biopharma, Inc. Presents Poster at Pancreasfest in Pittsburgh, Pa.

Results of Phase 1 Safety Study of SBP-101 for Pancreatic Ductal AdenocarcinomaPancreasFest is an ...

ChemoCentryx Announces Two Upcoming Presentations at the 55th ERA-EDTA Congress

MOUNTAIN VIEW, Calif., May 23, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq:CCXI), today announced ...